EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advanced extracellular vesicle immunotherapy

Jingjing Zhang, Yunfei Mu, Xianyue Ji, Xiaoting Jiang, Ruiheng Wang, Xianguang Ding, Lianhui Wang

FlexMat · 2026-03 · 3 (1) · 117-143

DOI: 10.1002/flm2.70030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FlexMat, online erschienen am 11.01.2026. Verfasst von Jingjing Zhang und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 280 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Graduate Research and Innovation Projects of Jiangsu Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has transformed cancer treatment by enabling the immune system to target tumors more precisely. However, challenges such as immunosuppression within the tumor microenvironment, off‐target effects, and limited success in treating solid tumors continue to hinder its broader effectiveness. Extracellular vesicles (EVs), secreted by various cell types, have drawn increasing interest for their potential to overcome these barriers. Tumor‐derived EVs can promote immune evasion but also carry tumor antigens that stimulate immune responses. Meanwhile, EVs from immune cells, such as dendritic cells and macrophages, can enhance immune function by delivering signaling molecules that support both innate and adaptive immunity. Advances in EV engineering have further improved their stability, targeting capabilities, and therapeutic potential. This review explores the dual roles of tumor‐derived and immune cell‐derived EVs in cancer immunotherapy, discusses recent progress in EV engineering that improves their clinical utility, and evaluates their potential to augment existing immunotherapies.

Förderung

  • National Natural Science Foundation of China
  • Graduate Research and Innovation Projects of Jiangsu Province

Zitieren

APA

Zhang, J., Mu, Y., Ji, X., Jiang, X., Wang, R., Ding, X., & Wang, L. (2026). Advanced extracellular vesicle immunotherapy. FlexMat, 3(1), 117-143. https://doi.org/10.1002/flm2.70030

Vancouver

Zhang J, Mu Y, Ji X, Jiang X, Wang R, Ding X, et al. Advanced extracellular vesicle immunotherapy. FlexMat. 2026;3(1):117-143. doi:10.1002/flm2.70030

BibTeX
@article{Zhang2026,
  author = {Zhang, Jingjing and Mu, Yunfei and Ji, Xianyue and Jiang, Xiaoting and Wang, Ruiheng and Ding, Xianguang and Wang, Lianhui},
  title = {Advanced extracellular vesicle immunotherapy},
  journal = {FlexMat},
  year = {2026},
  volume = {3},
  number = {1},
  pages = {117--143},
  doi = {10.1002/flm2.70030}
}
Kostenlos starten →